BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,010,236 | -28.0% | 2,067,100 | -13.1% | 0.03% | -25.7% |
| Q2 2023 | $108,368,169 | -14.0% | 2,379,067 | -23.5% | 0.04% | -16.7% |
| Q1 2023 | $126,057,974 | +86118.8% | 3,108,168 | +8.4% | 0.04% | -2.3% |
| Q4 2022 | $146,207 | -99.9% | 2,868,424 | +9.9% | 0.04% | -20.4% |
| Q3 2022 | $140,665,000 | -12.8% | 2,610,795 | +4.0% | 0.05% | -6.9% |
| Q2 2022 | $161,334,000 | -15.6% | 2,511,247 | +1.9% | 0.06% | -1.7% |
| Q1 2022 | $191,144,000 | -10.4% | 2,464,360 | -0.8% | 0.06% | -7.8% |
| Q4 2021 | $213,323,000 | +9.2% | 2,484,928 | +2.3% | 0.06% | +1.6% |
| Q3 2021 | $195,391,000 | +16.9% | 2,428,747 | +17.0% | 0.06% | +18.9% |
| Q2 2021 | $167,171,000 | +27.3% | 2,076,168 | +33.4% | 0.05% | +23.3% |
| Q1 2021 | $131,305,000 | +9.1% | 1,556,395 | +3.8% | 0.04% | 0.0% |
| Q4 2020 | $120,327,000 | +9.6% | 1,499,794 | +9.8% | 0.04% | -8.5% |
| Q3 2020 | $109,820,000 | +2.3% | 1,365,834 | +9.6% | 0.05% | 0.0% |
| Q2 2020 | $107,320,000 | +10.0% | 1,246,672 | +3.7% | 0.05% | -7.8% |
| Q1 2020 | $97,604,000 | -4.4% | 1,202,098 | -1.6% | 0.05% | +37.8% |
| Q4 2019 | $102,121,000 | -5.2% | 1,221,271 | -0.8% | 0.04% | -11.9% |
| Q3 2019 | $107,701,000 | +7.6% | 1,231,451 | +0.8% | 0.04% | +7.7% |
| Q2 2019 | $100,058,000 | +1.2% | 1,221,714 | +0.5% | 0.04% | 0.0% |
| Q1 2019 | $98,878,000 | +24.6% | 1,216,240 | +0.9% | 0.04% | +8.3% |
| Q4 2018 | $79,362,000 | -13.3% | 1,205,779 | +1.5% | 0.04% | +2.9% |
| Q3 2018 | $91,588,000 | +5.4% | 1,188,146 | +0.9% | 0.04% | 0.0% |
| Q2 2018 | $86,928,000 | +7.3% | 1,177,229 | -5.5% | 0.04% | +2.9% |
| Q1 2018 | $81,038,000 | +1.4% | 1,245,973 | +0.8% | 0.03% | +3.0% |
| Q4 2017 | $79,917,000 | -5.9% | 1,236,272 | -8.7% | 0.03% | -10.8% |
| Q3 2017 | $84,951,000 | +4.6% | 1,353,860 | +0.9% | 0.04% | 0.0% |
| Q2 2017 | $81,198,000 | +15.8% | 1,341,255 | -0.8% | 0.04% | +8.8% |
| Q1 2017 | $70,142,000 | +17.1% | 1,352,477 | +0.1% | 0.03% | +13.3% |
| Q4 2016 | $59,883,000 | -10.0% | 1,350,541 | -3.4% | 0.03% | -16.7% |
| Q3 2016 | $66,520,000 | +13.0% | 1,397,587 | +7.3% | 0.04% | +5.9% |
| Q2 2016 | $58,881,000 | +15.4% | 1,302,160 | +4.9% | 0.03% | +9.7% |
| Q1 2016 | $51,004,000 | +36.1% | 1,241,534 | +26.4% | 0.03% | +34.8% |
| Q4 2015 | $37,484,000 | +25.7% | 982,568 | +8.3% | 0.02% | +15.0% |
| Q3 2015 | $29,814,000 | -53.7% | 907,553 | -1.5% | 0.02% | -48.7% |
| Q2 2015 | $64,459,000 | +11.8% | 921,630 | +9.5% | 0.04% | +8.3% |
| Q1 2015 | $57,654,000 | -3.3% | 841,676 | +3.5% | 0.04% | -7.7% |
| Q4 2014 | $59,611,000 | +11.1% | 813,285 | +8.8% | 0.04% | +2.6% |
| Q3 2014 | $53,633,000 | +6.2% | 747,274 | +7.0% | 0.04% | +8.6% |
| Q2 2014 | $50,507,000 | +22.9% | 698,541 | +25.1% | 0.04% | +12.9% |
| Q1 2014 | $41,093,000 | +13.3% | 558,526 | +7.1% | 0.03% | +10.7% |
| Q4 2013 | $36,273,000 | +5.5% | 521,563 | -0.3% | 0.03% | -6.7% |
| Q3 2013 | $34,368,000 | -2.7% | 523,165 | +2.6% | 0.03% | -9.1% |
| Q2 2013 | $35,317,000 | – | 509,798 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |